Chemoimmunotherapy (DTIC and Corynebacterium parvum) for disseminated malignant melanoma
Karakousis, C.P.; Didolkar, M.S.; Han, T.
Cancer Treatment Reports 65(9-10): 925-926
1981
ISSN/ISBN: 0361-5960 PMID: 7273032 Document Number: 179211
Document emailed within 1 workday
Related Documents
Karakousis, C.P.; Didolkar, M.S.; Lopez, R.; Baffi, R.; Moore, R.; Holyoke, E.D. 1979: Chemoimmunotherapy (DTIC and Corynebacterium parvum) as adjuvant treatment in malignant melanoma Cancer Treatment Reports 63(11-12): 1739-1743Ramseur, W.L.; Richards, F.; Muss, H.B.; Rhyne, L.; Cooper, M.R.; White, D.R.; Stuart, J.J.; Spurr, C.L. 1978: Chemoimmunotherapy for disseminated malignant melanoma: a prospective randomized study Cancer Treatment Reports 62(7): 1085-1087
Einhorn, L.H.; Furnas, B. 1977: Combination chemotherapy for disseminated malignant melanoma with DTIC, vincristine, and methyl-CCNU Cancer Treatment Reports 61(5): 881-883
Ahmann, D.L.; Edmonson, J.H.; Frytak, S.; Kvols, L.K.; Bisel, H.F.; Rubin, J. 1978: Phase Ii study of ICRF-159 versus combination cis-dichlorodiammineplatinum(II) and DTIC in patients with disseminated malignant melanoma Cancer Treatment Reports 62(1): 151-153
Gershanovich, M.L.; Akimov, M.A. 2004: Chemoimmunotherapy with dacarbazine and aranose combined with interferon-alpha in disseminated cutaneous melanoma Voprosy Onkologii 50(2): 179-183
Bolling, R.; Meyer-Hamme, S.; Schauder, S. 1980: Photosensitization with DTIC therapy in metastatic malignant melanoma Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 31(11): 602-605
Foresti, V.; Scolari, N.; Villa, A.; Parisio, E. 1989: Anatomical study of the fibrosing action of Corynebacterium parvum in malignant pleural effusion Minerva Medica 80(10): 1069-1072
Didolkar, M.S.; Baffi, R.R.; Catane, R.; Kaufman, J.; Holyoke, E.D. 1977: Use of methyl-CCNU and procarbazine in advanced malignant melanoma resistant to DTIC therapy Cancer Treatment Reports 61(9): 1738-1739
Jimbow, K.; Takahashi, H.; Ishihara, K.; Hayasaka, K.; Kukita, A.; Seki, Y.; Ikeda, S.; Terakado, T. 1982: Malignant melanoma in Japan: unique distribution and effect of DAV chemoimmunotherapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 9(11): 1942-1949
Chen, M.F.; Suzuki, H.; Yano, S. 1992: Induction of murine lymphokine-activated killer-like cells by Corynebacterium parvum (C. parvum) in vitro: lysis of tumor cells and macrophages by C. parvum-induced killer cells Anticancer Research 12(2): 451-456
Khayat, D.; Coeffic, D. 2000: Chemotherapy and chemoimmunotherapy for metastatic malignant melanoma: review and recent advances Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(Suppl 2): 238-247
Marel, M.; Pospísil, M.; Fiserová, A.; Melínová, L.; Skácel, Z.; Bednár, M. 1990: Monitoring natural killer cell activity in the blood of patients with malignant pleural effusion after intrapleural administration of Corynebacterium parvum Casopis Lekaru Ceskych 129(16): 498-500
Dobrek, Z. 1985: Clinical trials of chemotherapy and chemoimmunotherapy of malignant melanoma with unfavorable prognosis after surgical treatment Wiadomosci Lekarskie 38(4): 265-270
Thatcher, N.; Swindell, R.; Crowther, D. 1979: Effects of repeated Corynebacterium parvum and BCG therapy on immune parameters: a weekly sequential study of melanoma patients. I. Changes in non-specific (NK, K and T cell) lymphocytotoxicity, peripheral blood counts and delayed hypersensitivity reactions Clinical and Experimental Immunology 36(2): 227-236
Chauvergne, J.; Clavel, B.; Klein, T.; Pammatau, E. 1978: Chemotherapy of disseminated malignant melanoma La Nouvelle Presse Medicale 7(30): 2658-2659
Medenica, R.; Girard, J.P.; Maurice, P. 1977: Clinical trial with Corynebacterium parvum Developments in Biological Standardization 38: 483-485
Cholakov, O.; Tsekov, K.; Beliaev, O.; Stefanov, P.; Cherveniakov, A. 2003: Disseminated malignant melanoma, complicated with upper-digestive hemorrhage Khirurgiia 59(3): 52-53
Zola, H. 1975: Mitogenicity of Corynebacterium parvum for mouse lymphocytes Clinical and Experimental Immunology 22(3): 514-521
Creagan, E.T.; Ahmann, D.L.; Long, H.J.; Frytak, S.; Sherwin, S.A.; Chang, M.N. 1987: Phase Ii study of recombinant interferon-gamma in patients with disseminated malignant melanoma Cancer Treatment Reports 71(9): 843-844
Gatenby, P.A.; Basten, A.; Tattersall, M.H.; Fox, R.M. 1980: Autoantibodies in cancer patients given Corynebacterium parvum/levamisole immunotherapy Lancet 1(8177): 1082